Published in Cardiovasc Res on August 07, 2012
Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) (2014) 0.81
C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation. Int Sch Res Notices (2014) 0.75
Regulation of the inflammatory response in cardiac repair. Circ Res (2012) 3.21
C-reactive protein and coronary heart disease: a critical review. J Intern Med (2008) 2.25
Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res (2009) 1.95
Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res (2005) 1.86
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (2005) 1.62
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci U S A (2007) 1.37
Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation (2005) 1.24
C-reactive protein in atherosclerosis: A causal factor? Cardiovasc Res (2006) 1.19
Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem (2002) 1.15
C-reactive protein isoforms differ in their effects on thrombus growth. Arterioscler Thromb Vasc Biol (2008) 1.09
Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res (2012) 0.99
Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk. Trends Cardiovasc Med (2009) 0.98
A redox switch in C-reactive protein modulates activation of endothelial cells. FASEB J (2011) 0.98
Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation (2004) 0.98
Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol (2009) 0.95
Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J (2011) 0.90
C-reactive protein: the pawn has been promoted to queen. Curr Atheroscler Rep (2003) 0.86
Monomeric C-reactive protein alters fibrin clot properties on endothelial cells. Thromb Res (2012) 0.86
The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res (2006) 4.38
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res (2005) 4.14
Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation (2007) 3.07
Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci U S A (2006) 2.85
The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol (2009) 2.80
Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol (2004) 2.61
TGF-β signaling in fibrosis. Growth Factors (2011) 2.42
Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res (2009) 2.38
Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol (2010) 2.35
Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol (2008) 1.97
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci (2013) 1.96
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res (2010) 1.94
Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am Coll Cardiol (2008) 1.90
Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension (2011) 1.79
CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol (2010) 1.69
Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res (2013) 1.61
Aging and Cardiac Fibrosis. Aging Dis (2011) 1.58
Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy (2003) 1.53
The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol (2006) 1.52
CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol (2008) 1.51
Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proc Natl Acad Sci U S A (2003) 1.50
Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol (2013) 1.46
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol (2008) 1.45
The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz) (2009) 1.45
Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem (2002) 1.41
Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta (2012) 1.41
Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol (2002) 1.38
The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev (2010) 1.30
Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. Circ Res (2009) 1.28
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol (2006) 1.27
MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets (2007) 1.16
Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation (2003) 1.14
IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J Immunol (2013) 1.14
The role of the thrombospondins in healing myocardial infarcts. Cardiovasc Hematol Agents Med Chem (2007) 1.10
Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest (2013) 1.10
Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation. Circulation (2002) 1.09
Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction. J Histochem Cytochem (2013) 1.06
Impact of myocardial structure and function postinfarction on diastolic strain measurements: implications for assessment of myocardial viability. Am J Physiol Heart Circ Physiol (2005) 1.05
Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol (2012) 1.02
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol (2005) 1.01
The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res (2012) 1.01
Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res (2006) 1.00
Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes. Curr Atheroscler Rep (2009) 0.92
Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Am J Physiol Endocrinol Metab (2013) 0.92
The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. J Am Coll Cardiol (2011) 0.91
Targeting the chemokines in myocardial inflammation. Circulation (2004) 0.91
Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity. Obesity (Silver Spring) (2008) 0.91
Myocardial extracellular matrix: an ever-changing and diverse entity. Circ Res (2014) 0.89
Vascular mural cells in healing canine myocardial infarcts. J Histochem Cytochem (2004) 0.89
The prognostic value of monocyte chemoattractant protein-1/CCL2 in acute coronary syndromes. J Am Coll Cardiol (2007) 0.85
Syndecan-1: a critical mediator in cardiac fibrosis. Hypertension (2010) 0.79
Chemokines in myocardial infarction: translating basic research into clinical medicine. Future Cardiol (2008) 0.79
Integrated multimodal-catheter imaging unveils principal relationships among ventricular electrical activity, anatomy, and function. Am J Physiol Heart Circ Physiol (2007) 0.78
Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regeneration. J Clin Invest (2015) 0.78
The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest (2017) 0.77
The cellular specificity of leptin-mediated actions in the infarcted heart. Cardiovasc Res (2010) 0.77
Stromal cell-derived factor-1-mediated angiogenesis for peripheral arterial disease: ready for prime time? Circulation (2011) 0.77